These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6737234)

  • 1. Ocular delivery of pilocarpine from erodible matrices.
    Grass GM; Cobby J; Makoid MC
    J Pharm Sci; 1984 May; 73(5):618-21. PubMed ID: 6737234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vehicle effects in ophthalmic bioavailability: an evaluation of polymeric inserts containing pilocarpine.
    Saettone MF; Giannaccini B; Chetoni P; Galli G; Chiellini E
    J Pharm Pharmacol; 1984 Apr; 36(4):229-34. PubMed ID: 6144768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physico-chemical, in vitro and in vivo characterisation of polymers for ocular use.
    Hartmann V; Keipert S
    Pharmazie; 2000 Jun; 55(6):440-3. PubMed ID: 10907252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of pluronic F127-based sustained-release ocular delivery systems for pilocarpine using the albino rabbit eye model.
    Desai SD; Blanchard J
    J Pharm Sci; 1998 Oct; 87(10):1190-5. PubMed ID: 9758675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Phytantriol-Based Lyotropic Liquid Crystalline Gel for Efficient Ophthalmic Delivery of Pilocarpine Nitrate.
    Wang X; Zhang Y; Huang J; Tian C; Xia M; Liu L; Li Z; Cao J; Gui S; Chu X
    AAPS PharmSciTech; 2019 Jan; 20(1):32. PubMed ID: 30603986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interactions between macromolecular adjuvants and drugs. Part 19: In vitro and in vivo testing of polyvinyl alcohol and other macromolecular adjuvants as vehicles for eyedrops (author's transl)].
    Keipert S; Voigt R; Karst R; Nowak R
    Pharmazie; 1979 Dec; 34(12):818-24. PubMed ID: 545352
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustained release ophthalmic formulations of pilocarpine.
    Deshpande SG; Shirolkar S
    J Pharm Pharmacol; 1989 Mar; 41(3):197-200. PubMed ID: 2568450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of topically applied pilocarpine on tear film pH.
    Longwell A; Birss S; Keller N; Moore D
    J Pharm Sci; 1976 Nov; 65(11):1654-7. PubMed ID: 11334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oily vehicle on ocular pilocarpine concentration.
    Salminen L
    Acta Ophthalmol (Copenh); 1979 Aug; 57(4):633-6. PubMed ID: 525286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 2: Precorneal retention and in vivo pharmacodynamic study.
    Rupenthal ID; Green CR; Alany RG
    Int J Pharm; 2011 Jun; 411(1-2):78-85. PubMed ID: 21453763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A gelatin-g-poly(N-isopropylacrylamide) biodegradable in situ gelling delivery system for the intracameral administration of pilocarpine.
    Lai JY; Hsieh AC
    Biomaterials; 2012 Mar; 33(7):2372-87. PubMed ID: 22182746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pluronic F127-based ocular delivery system containing biodegradable polyisobutylcyanoacrylate nanocapsules of pilocarpine.
    Desai SD; Blanchard J
    Drug Deliv; 2000; 7(4):201-7. PubMed ID: 11195426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of pilocarpine-loaded chitosan/Carbopol nanoparticles.
    Kao HJ; Lin HR; Lo YL; Yu SP
    J Pharm Pharmacol; 2006 Feb; 58(2):179-86. PubMed ID: 16451745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration-dependent precorneal loss of pilocarpine in rabbit eyes.
    Urtti A; Salminen L
    Acta Ophthalmol (Copenh); 1985 Oct; 63(5):502-6. PubMed ID: 4072629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified beta-cyclodextrin (SBE7-beta-CyD) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits.
    Jarho P; Järvinen K; Urtti A; Stella VJ; Järvinen T
    J Pharm Pharmacol; 1996 Mar; 48(3):263-9. PubMed ID: 8737051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular penetration of pilocarpine: the effect of pH on the ocular penetration of pilocarpine.
    Ramer RM; Gasset AR
    Ann Ophthalmol; 1975 Feb; 7(2):293-6. PubMed ID: 235874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular penetration of pilocarpine in rabbits.
    Green K; Downs SJ
    Arch Ophthalmol; 1975 Nov; 93(11):1165-8. PubMed ID: 1191106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric pseudolatices bearing pilocarpine for controlled ocular delivery.
    Vyas SP; Ramchandraiah S; Jain CP; Jain SK
    J Microencapsul; 1992; 9(3):347-55. PubMed ID: 1403485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of vehicle on pilocarpine-induced miosis.
    Saari M; Koskela P; Masar SE
    Acta Ophthalmol (Copenh); 1978; 56(4):496-503. PubMed ID: 735764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of influence of rabbit nictitating membrane of miosis effect of pilocarpine.
    DeSantis LM; Schoenwald RD
    J Pharm Sci; 1978 Aug; 67(8):1189-90. PubMed ID: 671268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.